Outcome of advanced stage (III/IV) intermediate-risk patients with mature B-NHL using rituximab plus FAB group B4 chemotherapy: a Children's Oncology Group report

被引:0
作者
Goldman, S. [1 ]
Smith, L. [2 ]
Anderson, J. R. [2 ]
Perkins, S. [3 ]
Harrison, L. [4 ]
Shiramizu, B. [9 ]
Sanger, W. [10 ]
Barth, M. [11 ]
Cairo, M. S. [4 ,5 ,6 ,7 ,8 ]
机构
[1] Med City Childrens Hosp, Div Pediat Hematol Oncol, Dallas, TX USA
[2] Univ Nebraska, Coll Publ Hlth, Dept Biostat, Omaha, NE 68182 USA
[3] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[4] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA
[5] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[6] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA
[7] New York Med Coll, Dept Microbiol, Valhalla, NY 10595 USA
[8] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA
[9] Univ Hawaii, Div Pediat Hematol Oncol, Honolulu, HI 96822 USA
[10] Univ Nebraska Med Ctr, Dept Cytogenet, Omaha, NE USA
[11] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
42
引用
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
[41]   Reduced and compressed cisplatin-based chemotherapy in children and adolescents with intermediate-risk extracranial malignant germ cell tumors: A report from the Children's Oncology Group. [J].
Shaikh, Furcian ;
Cullen, John W. ;
Olson, Thomas Arthur ;
Pashankar, Farzana ;
Malogolowkin, Marcio H. ;
Amatruda, James ;
Villaluna, Doojduen ;
Krailo, Mark D. ;
Billmire, Deborah F. ;
Rescorla, Frederick ;
Egler, Rachel A. ;
Dicken, Bryan J. ;
Ross, Jonathan H. ;
Schlatter, Marc ;
Rodriguez-Galindo, Carlos ;
Frazier, A. Lindsay .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[42]   Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531 [J].
Brown, Erin G. ;
Adkins, E. Stanton ;
Mattei, Peter ;
Hoffer, Fredric A. ;
Wootton-Gorges, Sandra L. ;
London, Wendy B. ;
Naranjo, Arlene ;
Schmidt, Mary L. ;
Hogarty, Michael D. ;
Irwin, Meredith S. ;
Cohn, Susan L. ;
Park, Julie R. ;
Maris, John M. ;
Bagatell, Rochelle ;
Twist, Clare J. ;
Nuchtern, Jed G. ;
Davidoff, Andrew M. ;
Newman, Erika A. ;
Lal, Dave R. .
JOURNAL OF PEDIATRIC SURGERY, 2025, 60 (01)
[43]   Southwest Oncology Group S0008: A Phase III Trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine, Plus Interleukin-2 and Interferon in Patients With High-Risk Melanoma-An Intergroup Study of Cancer and Leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group [J].
Flaherty, Lawrence E. ;
Othus, Megan ;
Atkins, Michael B. ;
Tuthill, Ralph J. ;
Thompson, John A. ;
Vetto, John T. ;
Haluska, Frank G. ;
Pappo, Alberto S. ;
Sosman, Jeffrey A. ;
Redman, Bruce G. ;
Moon, James ;
Ribas, Antoni ;
Kirkwood, John M. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (33) :3771-+
[44]   A Study of Rituximab and Ifosfamide, Carboplatin, and Etoposide Chemotherapy in Children with Recurrent/Refractory B-Cell (CD20+) Non-Hodgkin Lymphoma and Mature B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group [J].
Griffin, Timothy C. ;
Weitzman, Sheila ;
Weinstein, Howard ;
Chang, Myron ;
Cairo, Mitchell ;
Hutchison, Robert ;
Shiramizu, Bruce ;
Wiley, Joseph ;
Woods, Deborah ;
Barnich, Margaret ;
Gross, Thomas G. .
PEDIATRIC BLOOD & CANCER, 2009, 52 (02) :177-181
[45]   Patterns of Relapse From a Phase III Study of Response-based Therapy for Intermediate-risk Hodgkin Lymphoma (AHOD0031): A Report From the Children's Oncology Group [J].
Dharmarajan, K. V. ;
Friedman, D. L. ;
Schwartz, C. L. ;
Chen, L. ;
FitzGerald, T. ;
McCarten, K. M. ;
Kessel, S. K. ;
Iandoli, M. ;
Constine, L. S. ;
Wolden, S. L. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03) :S5-S6
[46]   Outcomes after Intermediate-Risk Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) and the Role of Allogeneic Stem Cell Transplantation (SCT): A Report from Children's Oncology Group (COG) AALL0433 [J].
Lew, Glen ;
Lu, Xiaomin ;
Yanofsky, Rochelle ;
Rheingold, Susan R. ;
Whitlock, James ;
An, Qi ;
Devidas, Meenakshi ;
Hastings, Caroline A. ;
Winick, Naomi J. ;
Carroll, William L. ;
Borowitz, Michael J. ;
Hunger, Stephen ;
Pulsipher, Michael A. .
BLOOD, 2014, 124 (21)
[47]   FACTORS THAT CONTRIBUTE TO INFERIOR SURVIVAL OF LOW-RISK STAGE 2B NEUROBLASTOMA PATIENTS: A CHILDREN'S ONCOLOGY GROUP STUDY [J].
Strother, Douglas R. ;
London, Wendy B. ;
Tagge, Edward ;
Shimada, Hiroyuki ;
Cohn, Susan L. .
PEDIATRIC BLOOD & CANCER, 2012, 59 (06) :995-995
[48]   Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531 [J].
Voeller, Julie ;
Katzenstein, Howard M. ;
Naranjo, Arlene ;
Tenney, Sheena C. ;
Chen, Lulu ;
London, Wendy B. ;
Handler, Michael H. ;
Schmidt, Mary Lou ;
Shimada, Hiroyuki ;
Hogarty, Michael D. ;
Gastier-Foster, Julie ;
Park, Julie R. ;
Cohn, Susan L. ;
Maris, John M. ;
Bagatell, Rochelle ;
Twist, Clare J. .
PEDIATRIC BLOOD & CANCER, 2025, 72 (01)
[49]   EFFECT OF RADIOTHERAPY TECHNIQUES (IMRT VS. 3D-CRT) ON OUTCOME IN PATIENTS WITH INTERMEDIATE-RISK RHABDOMYOSARCOMA ENROLLED IN COG D9803-A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP [J].
Lin, Chi ;
Donaldson, Sarah S. ;
Meza, Jane L. ;
Anderson, James R. ;
Lyden, Elizabeth R. ;
Brown, Christopher K. ;
Morano, Karen ;
Laurie, Fran ;
Arndt, Carola A. ;
Enke, Charles A. ;
Breneman, John C. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05) :1764-1770
[50]   Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group [J].
Spunt, SL ;
Smith, LM ;
Ruymann, FB ;
Qualman, SJ ;
Donaldson, SS ;
Rodeberg, DA ;
Anderson, JR ;
Crist, WM ;
Link, MP .
CLINICAL CANCER RESEARCH, 2004, 10 (18) :6072-6079